Proliferation rate of somatic cells affects reprogramming efficiency

Journal of Biological Chemistry

Volumn 288, Issue 14, 2013, Pages 9767-9778

  Xu, Yongyu ^a,b   Wei, Xiaoyuan ^a,b   Wang, Min ^b   Zhang, Ru ^a   Fu, Yanbin ^a,b   Xing, Mingzhe ^a,b   Hua, Qiuhong ^a   Xie, Xin ^a,b,c  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c National Center for Drug Screening   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE CONTROL; CELL REPLACEMENT THERAPY; COMPLEMENTATION; DRUG SCREENING; MOUSE EMBRYONIC FIBROBLASTS; NEW APPROACHES; PROLIFERATION RATE; SMALL MOLECULE INHIBITOR;

CELL CULTURE; CELL PROLIFERATION; FIBROBLASTS; GENE EXPRESSION; MAMMALS;

EFFICIENCY;

APHIDICOLIN; CAYLIN 1; CISPLATIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; NUTLIN 3; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO CELL; FIBROBLAST; GENE EXPRESSION; GENE FUNCTION; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; SOMATIC CELL; TETRAPLOIDY;

ALKALINE PHOSPHATASE; ANIMALS; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; FEMALE; FIBROBLASTS; GENETIC COMPLEMENTATION TEST; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED ICR; OCTAMER TRANSCRIPTION FACTOR-3; PLOIDIES; PROTO-ONCOGENE PROTEINS C-MYC; REAL-TIME POLYMERASE CHAIN REACTION; RETROVIRIDAE; SOXB1 TRANSCRIPTION FACTORS; STEM CELLS;

IPS; MUS;

EID: 84875997644     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.403881     Document Type: Article

References (83)

1. Takahashi, K., and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676
2. Stadtfeld, M., and Hochedlinger, K. (2010) Induced pluripotency. History, mechanisms, and applications. Genes Dev. 24, 2239-2263
3. Kim, J. B., Greber, B., Araúzo-Bravo, M. J., Meyer, J., Park, K. I., Zaehres, H., and Schöler, H. R. (2009) Direct reprogramming of human neural stem cells by OCT4. Nature 461, 649-3
4. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., and Yamanaka, S. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106
5. Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., Kaji, K., Sung, H. K., and Nagy, A. (2009) PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766-770
6. Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., and Woltjen, K. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771-775
7. Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., Siuzdak, G., Schöler, H. R., Duan, L., and Ding, S. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384
8. Feng, B., Ng, J. H., Heng, J. C., and Ng, H. H. (2009) Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4, 301-312
9. Li, W., and Ding, S. (2010) Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol. Sci. 31, 36-45
10. Sridharan, R., Tchieu, J., Mason, M. J., Yachechko, R., Kuoy, E., Horvath, S., Zhou, Q., and Plath, K. (2009) Role of the murine reprogramming factors in the induction of pluripotency. Cell 136, 364-377
11. Cartwright, P., McLean, C., Sheppard, A., Rivett, D., Jones, K., and Dalton, S. (2005) LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132, 885-896
12. Meyer, N., and Penn, L. Z. (2008) Reflecting on 25 years with MYC. Nat. Rev. Cancer 8, 976-990
13. Nakagawa, M., Takizawa, N., Narita, M., Ichisaka, T., and Yamanaka, S. (2010) Promotion of direct reprogramming by transformation-deficient Myc. Proc. Natl. Acad. Sci. U.S.A. 107, 14152-14157
14. Singh, A. M., and Dalton, S. (2009) The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 5, 141-149
15. Chen, J., Liu, J., Han, Q., Qin, D., Xu, J., Chen, Y., Yang, J., Song, H., Yang, D., Peng, M., He, W., Li, R., Wang, H., Gan, Y., Ding, K., Zeng, L., Lai, L., Esteban, M. A., and Pei, D. (2010) Towards an optimized culture medium for the generation of mouse induced pluripotent stem cells. J. Biol. Chem. 285, 31066-31072
16. Chen, M., Huang, J., Yang, X., Liu, B., Zhang, W., Huang, L., Deng, F., Ma, J., Bai, Y., Lu, R., Huang, B., Gao, Q., Zhuo, Y., and Ge, J. (2012) Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming. PLoS One 7, e28203
17. Wang, Q., Xu, X., Li, J., Liu, J., Gu, H., Zhang, R., Chen, J., Kuang, Y., Fei, J., Jiang, C., Wang, P., Pei, D., Ding, S., and Xie, X. (2011) Lithium, an antipsychotic drug, greatly enhances the generation of induced pluripotent stem cells. Cell Res. 21, 1424-1435
18. Plück, A., and Klasen, C. (2009) Generation of chimeras by microinjection. Methods Mol. Biol. 561, 199-217
19. Do, J. T., and Schöler, H. R. (2004) Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 22, 941-949
20. Utikal, J., Polo, J. M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R. M., Khalil, A., Rheinwald, J. G., and Hochedlinger, K. (2009) Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460, 1145-1148
21. Wernig, M., Meissner, A., Cassady, J. P., and Jaenisch, R. (2008) c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10-12
22. Chen, J., Liu, J., Chen, Y., Yang, J., Chen, J., Liu, H., Zhao, X., Mo, K., Song, H., Guo, L., Chu, S., Wang, D., Ding, K., and Pei, D. (2011) Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics. Cell Res. 21, 884-894
23. Araki, R., Hoki, Y., Uda, M., Nakamura, M., Jincho, Y., Tamura, C., Sunayama, M., Ando, S., Sugiura, M., Yoshida, M. A., Kasama, Y., and Abe, M. (2011) Crucial role of c-Myc in the generation of induced pluripotent stem cells. Stem Cells 29, 1362-1370
24. Lüscher, B., and Larsson, L. G. (2007) The world according to MYC. Conference on MYC and the transcriptional control of proliferation and oncogenesis. EMBO Rep. 8, 1110-1114
25. Grandori, C., Cowley, S. M., James, L. P., and Eisenman, R. N. (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699
26. Hindley, C., and Philpott, A. (2012) Coordination of cell cycle and differentiation in the developing nervous system. Biochem. J. 444, 375-382
27. Miller, J. P., Yeh, N., Vidal, A., and Koff, A. (2007) Interweaving the cell cycle machinery with cell differentiation. Cell Cycle 6, 2932-2938
28. Dang, C. V. (2012) MYC on the path to cancer. Cell 149, 22-35
29. Malynn, B. A., de Alboran, I. M., O'Hagan, R. C., Bronson, R., Davidson, L., DePinho, R. A., and Alt, F. W. (2000) N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 14, 1390-1399
30. Knoepfler, P. S., Cheng, P. F., and Eisenman, R. N. (2002) N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 16, 2699-2712
31. Coppola, J. A., and Cole, M. D. (1986) Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature 320, 760-763
32. Langdon, W. Y., Harris, A. W., Cory, S., and Adams, J. M. (1986) The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 47, 11-18
33. Habib, T., Park, H., Tsang, M., de Alborán, I. M., Nicks, A., Wilson, L., Knoepfler, P. S., Andrews, S., Rawlings, D. J., Eisenman, R. N., and Iritani, B. M. (2007) Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. J. Cell Biol. 179, 717-731
34. Gandarillas, A., and Watt, F. M. (1997) c-Myc promotes differentiation of human epidermal stem cells. Genes Dev. 11, 2869-2882
35. Wilson, A., Murphy, M. J., Oskarsson, T., Kaloulis, K., Bettess, M. D., Oser, G. M., Pasche, A. C., Knabenhans, C., Macdonald, H. R., and Trumpp, A. (2004) c-Myc controls the balance between hematopoietic stem cell selfrenewal and differentiation. Genes Dev. 18, 2747-2763
36. Banito, A., Rashid, S. T., Acosta, J. C., Li, S., Pereira, C. F., Geti, I., Pinho, S., Silva, J. C., Azuara, V., Walsh, M., Vallier, L., and Gil, J. (2009) Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 23, 2134-2139
37. Trumpp, A., Refaeli, Y., Oskarsson, T., Gasser, S., Murphy, M., Martin, G. R., and Bishop, J. M. (2001) c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414, 768-773
38. Hurlin, P. J., Zhou, Z. Q., Toyo-oka, K., Ota, S., Walker, W. L., Hirotsune, S., and Wynshaw-Boris, A. (2003) Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J. 22, 4584-4596
39. Ota, S., Zhou, Z. Q., Link, J. M., and Hurlin, P. J. (2009) The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects. Hum. Mol. Genet. 18, 2609-2621
40. Knoepfler, P. S., Zhang, X. Y., Cheng, P. F., Gafken, P. R., McMahon, S. B., and Eisenman, R. N. (2006) Myc influences global chromatin structure. EMBO J. 25, 2723-2734
41. Ying, Q. L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., and Smith, A. (2008) The ground state of embryonic stem cell self-renewal. Nature 453, 519-523
42. Hishida, T., Nozaki, Y., Nakachi, Y., Mizuno, Y., Okazaki, Y., Ema, M., Takahashi, S., Nishimoto, M., and Okuda, A. (2011) Indefinite self-renewal of ESCs through Myc/Max transcriptional complex-independent mechanisms. Cell Stem Cell 9, 37-49
43. Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez- Capetillo, O., Serrano, M., and Blasco, M. A. (2009) A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149-1153
44. Wang, T., Chen, K., Zeng, X., Yang, J., Wu, Y., Shi, X., Qin, B., Zeng, L., Esteban, M. A., Pan, G., and Pei, D. (2011) The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 9, 575-587
45. Ruiz, S., Panopoulos, A. D., Herrerías, A., Bissig, K. D., Lutz, M., Berggren, W. T., Verma, I. M., and Izpisua Belmonte, J. C. (2011)Ahigh proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr. Biol. 21, 45-52
46. Papp, B., and Plath, K. (2011) Reprogramming to pluripotency. Stepwise resetting of the epigenetic landscape. Cell Res. 21, 486-501
47. Shi, Y., Desponts, C., Do, J. T., Hahm, H. S., Schöler, H. R., and Ding, S. (2008) Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568-574
48. Shi, Y., Do, J. T., Desponts, C., Hahm, H. S., Schöler, H. R., and Ding, S. (2008) A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2, 525-528
49. Cho, H. S., Kelly, J. D., Hayami, S., Toyokawa, G., Takawa, M., Yoshimatsu, M., Tsunoda, T., Field, H. I., Neal, D. E., Ponder, B. A., Nakamura, Y., and Hamamoto, R. (2011) Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia 13, 676-684
50. Stresemann, C., Brueckner, B., Musch, T., Stopper, H., and Lyko, F. (2006) Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res. 66, 2794-2800
51. Kunert-Radek, J., Stepien, H., Lyson, K., and Pawlikowski, M. (1990) Effects of calcium channel modulators on the proliferation of mouse spleen lymphocytes in vitro. Agents Actions 29, 254-258
52. Li, W., Zhou, H., Abujarour, R., Zhu, S., Young Joo, J., Lin, T., Hao, E., Schöler, H. R., Hayek, A., and Ding, S. (2009) Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 27, 2992-3000
53. Lyssiotis, C. A., Foreman, R. K., Staerk, J., Garcia, M., Mathur, D., Markoulaki, S., Hanna, J., Lairson, L. L., Charette, B. D., Bouchez, L. C., Bollong, M., Kunick, C., Brinker, A., Cho, C. Y., Schultz, P. G., and Jaenisch, R. (2009) Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc. Natl. Acad. Sci. U.S.A. 106, 8912-8917
54. Zaharevitz, D. W., Gussio, R., Leost, M., Senderowicz, A. M., Lahusen, T., Kunick, C., Meijer, L., and Sausville, E. A. (1999) Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. Cancer Res. 59, 2566-2569
55. Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., and Melton, D. A. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26, 1269-1275
56. Cinatl, J., Jr., Cinatl, J., Driever, P. H., Kotchetkov, R., Pouckova, P., Kornhuber, B., and Schwabe, D. (1997) Sodium valproate inhibits in vivo growth of human neuroblastoma cells. Anticancer Drugs 8, 958-963
57. Xia, Q., Sung, J., Chowdhury, W., Chen, C. L., Höti, N., Shabbeer, S., Carducci, M., and Rodriguez, R. (2006) Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo. Cancer Res. 66, 7237-7244
58. Bug, G., Gül, H., Schwarz, K., Pfeifer, H., Kampfmann, M., Zheng, X., Beissert, T., Boehrer, S., Hoelzer, D., Ottmann, O. G., and Ruthardt, M. (2005) Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res. 65, 2537-2541
59. Schmidt, K., Gust, R., and Jung, M. (1999) Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. Arch. Pharm. (Weinheim) 332, 353-357
60. Medina, V., Edmonds, B., Young, G. P., James, R., Appleton, S., and Zalewski, P. D. (1997) Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase). Dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res. 57, 3697-3707
61. Butler, L. M., Agus, D. B., Scher, H. I., Higgins, B., Rose, A., Cordon-Cardo, C., Thaler, H. T., Rifkind, R. A., Marks, P. A., and Richon, V. M. (2000) Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res. 60, 5165-5170
62. Richon, V. M., Zhou, X., Rifkind, R. A., and Marks, P. A. (2001) Histone deacetylase inhibitors. Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers. Blood Cells Mol. Dis. 27, 260-264
63. Kelly, W. K., and Marks, P. A. (2005) Drug insight. Histone deacetylase inhibitors. Development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nat. Clin. Pract. Oncol. 2, 150-157
64. Weller, E. M., Poot, M., and Hoehn, H. (1993) Induction of replicative senescence by 5-azacytidine. Fundamental cell kinetic differences between human diploid fibroblasts and NIH-3T3 cells. Cell Prolif 26, 45-54
65. Kim, C. H., Cheng, S. L., and Kim, G. S. (1999) Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells. Possible mechanisms of glucocorticoid-induced bone loss. J. Endocrinol. 162, 371-379
66. Liu, H., Huang, X., Wang, H., Shen, A., and Cheng, C. (2009) Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line. Brain Res. 1265, 1-12
67. Bavaresco, L., Bernardi, A., Braganhol, E., Wink, M. R., and Battastini, A. M. (2007) Dexamethasone inhibits proliferation and stimulates ecto-5′-nucleotidase/CD73 activity in C6 rat glioma cell line. J. Neurooncol. 84, 1-8
68. Luo, J. C., Chi, C. W., Lin, H. Y., Chang, F. Y., Lu, C. L., Chen, C. Y., and Lee, S. D. (2007) Dexamethasone inhibits epidermal growth factor-stimulated gastric epithelial cell proliferation. J. Pharmacol. Exp. Ther. 320, 687-694
69. Marson, A., Foreman, R., Chevalier, B., Bilodeau, S., Kahn, M., Young, R. A., and Jaenisch, R. (2008) Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3, 132-135
70. Golestaneh, N., Beauchamp, E., Fallen, S., Kokkinaki, M., Uren, A., and Dym, M. (2009) Wnt signaling promotes proliferation and stemness regulation of spermatogonial stem/progenitor cells. Reproduction 138, 151-162
71. Shang, Y. C., Wang, S. H., Xiong, F., Zhao, C. P., Peng, F. N., Feng, S. W., Li, M. S., Li, Y., and Zhang, C. (2007) Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells. Acta Pharmacol. Sin. 28, 1761-1774
72. Liu, H., Fergusson, M. M., Castilho, R. M., Liu, J., Cao, L., Chen, J., Malide, D., Rovira, I. I., Schimel, D., Kuo, C. J., Gutkind, J. S., Hwang, P. M., and Finkel, T. (2007) Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317, 803-806
73. Tighe, A., Ray-Sinha, A., Staples, O. D., and Taylor, S. S. (2007) GSK-3 inhibitors induce chromosome instability. BMC Cell Biol. 8, 34
74. Zhu, S., Li, W., Zhou, H., Wei, W., Ambasudhan, R., Lin, T., Kim, J., Zhang, K., and Ding, S. (2010) Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7, 651-655
75. Tojo, M., Hamashima, Y., Hanyu, A., Kajimoto, T., Saitoh, M., Miyazono, K., Node, M., and Imamura, T. (2005) The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-β. Cancer Sci. 96, 791-800
76. Yamamura, S., Matsumura, N., Mandai, M., Huang, Z., Oura, T., Baba, T., Hamanishi, J., Yamaguchi, K., Kang, H. S., Okamoto, T., Abiko, K., Mori, S., Murphy, S. K., and Konishi, I. (2012) The activated transforming growth factor-β signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer. Int. J. Cancer 130, 20-28
77. Watabe, T., Nishihara, A., Mishima, K., Yamashita, J., Shimizu, K., Miyazawa, K., Nishikawa, S., and Miyazono, K. (2003) TGF-β receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J. Cell Biol. 163, 1303-1311
78. Sebolt-Leopold, J. S., and Herrera, R. (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4, 937-947
79. Esteban, M. A., Wang, T., Qin, B., Yang, J., Qin, D., Cai, J., Li, W., Weng, Z., Chen, J., Ni, S., Chen, K., Li, Y., Liu, X., Xu, J., Zhang, S., Li, F., He, W., Labuda, K., Song, Y., Peterbauer, A., Wolbank, S., Redl, H., Zhong, M., Cai, D., Zeng, L., and Pei, D. (2010) Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71-79
80. Ichida, J. K., Blanchard, J., Lam, K., Son, E. Y., Chung, J. E., Egli, D., Loh, K. M., Carter, A. C., Di Giorgio, F. P., Koszka, K., Huangfu, D., Akutsu, H., Liu, D. R., Rubin, L. L., and Eggan, K. (2009) A small-molecule inhibitor of TGF-β signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5, 491-503
81. Mali, P., Chou, B. K., Yen, J., Ye, Z., Zou, J., Dowey, S., Brodsky, R. A., Ohm, J. E., Yu, W., Baylin, S. B., Yusa, K., Bradley, A., Meyers, D. J., Mukherjee, C., Cole, P. A., and Cheng, L. (2010) Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 28, 713-720
82. Rocchi, P., Ferreri, A. M., Simone, G., Granchi, D., Paolucci, P., and Paolucci, G. (1992) Growth inhibitory and differentiating effects of sodium butyrate on human neuroblastoma cells in culture. Anticancer Res. 12, 917-920
83. Kaufmann, L., Marinescu, G., Nazarenko, I., Thiele, W., Oberle, C., Sleeman, J., and Blattner, C. (2011) LiCl induces TNF-α and FasL production, thereby stimulating apoptosis in cancer cells. Cell Commun. Signal. 9, 15